TY - JOUR
T1 - Outcomes of protocol-driven care of critically ill severely anemic patients for whom blood transfusion is not an option
AU - Shander, Aryeh
AU - Javidroozi, Mazyar
AU - Gianatiempo, Carmine
AU - Gandhi, Nisha
AU - Lui, John
AU - Califano, Frank
AU - Kaufman, Margit
AU - Naqvi, Sajjad
AU - Syed, Faraz
AU - Aregbeyen, Oshuare
N1 - Publisher Copyright:
© 2016 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc.
PY - 2016/6/1
Y1 - 2016/6/1
N2 - Objective: To compare the outcomes of severely anemic critically ill patients for whom transfusion is not an option ("bloodless" patients) with transfused patients. Design: Cohort study with propensity score matching. Setting: ICU of a referral center. Patients: One hundred seventy-eight bloodless and 441 transfused consecutive severely anemic, critically ill patients, admitted between May 1996 and April 2011, and having at least one hemoglobin level less than or equal to 8 g/dL within 24 hours of ICU admission. Patients with diagnosis of brain injury, acute myocardial infarction, or status postcardiac surgery were excluded. Interventions: Allogeneic RBC transfusion during ICU stay. Measurements and Main Results: Primary outcome was in-hospital mortality. Other outcomes were ICU mortality, readmission to ICU, new electrocardiographic or cardiac enzyme changes suggestive of cardiac ischemia or injury, and new positive blood culture result. Transfused patients were older, had higher hemoglobin level at admission, and had higher Acute Physiology and Chronic Health Evaluation II score. Hospital mortality rates were 24.7% in bloodless and 24.5% in transfused patients (odds ratio, 1.01; 95% CI, 0.68-1.52; p = 0.95). Adjusted odds ratio of hospital mortality was 1.52 (95% CI, 0.95-2.43; p = 0.08). No significant difference in ICU readmission or positive blood culture results was observed. Analysis of propensity score-matched cohorts provided similar results. Conclusions: Overall risk of mortality in severely anemic critically ill bloodless patients appeared to be comparable with transfused patients, albeit the latter group had older age and higher Acute Physiology and Chronic Health Evaluation II score. Use of a protocol to manage anemia in these patients in a center with established patient blood management and bloodless medicine and surgery programs is feasible and likely to contribute to improved outcome, whereas more studies are needed to better delineate the impact of such programs.
AB - Objective: To compare the outcomes of severely anemic critically ill patients for whom transfusion is not an option ("bloodless" patients) with transfused patients. Design: Cohort study with propensity score matching. Setting: ICU of a referral center. Patients: One hundred seventy-eight bloodless and 441 transfused consecutive severely anemic, critically ill patients, admitted between May 1996 and April 2011, and having at least one hemoglobin level less than or equal to 8 g/dL within 24 hours of ICU admission. Patients with diagnosis of brain injury, acute myocardial infarction, or status postcardiac surgery were excluded. Interventions: Allogeneic RBC transfusion during ICU stay. Measurements and Main Results: Primary outcome was in-hospital mortality. Other outcomes were ICU mortality, readmission to ICU, new electrocardiographic or cardiac enzyme changes suggestive of cardiac ischemia or injury, and new positive blood culture result. Transfused patients were older, had higher hemoglobin level at admission, and had higher Acute Physiology and Chronic Health Evaluation II score. Hospital mortality rates were 24.7% in bloodless and 24.5% in transfused patients (odds ratio, 1.01; 95% CI, 0.68-1.52; p = 0.95). Adjusted odds ratio of hospital mortality was 1.52 (95% CI, 0.95-2.43; p = 0.08). No significant difference in ICU readmission or positive blood culture results was observed. Analysis of propensity score-matched cohorts provided similar results. Conclusions: Overall risk of mortality in severely anemic critically ill bloodless patients appeared to be comparable with transfused patients, albeit the latter group had older age and higher Acute Physiology and Chronic Health Evaluation II score. Use of a protocol to manage anemia in these patients in a center with established patient blood management and bloodless medicine and surgery programs is feasible and likely to contribute to improved outcome, whereas more studies are needed to better delineate the impact of such programs.
KW - Jehovah's Witnesses
KW - anemia
KW - blood transfusion
KW - bloodless medical and surgical procedures
KW - critical illness
UR - http://www.scopus.com/inward/record.url?scp=84955611473&partnerID=8YFLogxK
U2 - 10.1097/CCM.0000000000001599
DO - 10.1097/CCM.0000000000001599
M3 - Article
C2 - 26807684
AN - SCOPUS:84955611473
SN - 0090-3493
VL - 44
SP - 1109
EP - 1115
JO - Critical Care Medicine
JF - Critical Care Medicine
IS - 6
ER -